A Hong Kong enterprise as defined in the Guangdong drug authority announcement, which must meet the following:

     a) An eligible proprietary Chinese medicine that has been used in Hong Kong for at least five years and holds a certificate of registration (HKC) or a notice of confirmation of transitional registration (HKP) under the Chinese Medicine Ordinance (Cap. 549);

     b) For the eligible product in (a), the applicant has on its own filed a Mainland marketing application for a traditional Hong Kong topical proprietary Chinese medicine with the Guangdong drug authority, and the authority has accepted it. The application must be made on the basis of Hong Kong registration; and

     c) For the marketing application in (b), the required registration fee has been paid as the authority asked, whether or not the product is ultimately approved for sale in the Mainland.

Eligibility follows the latest measures and updated definitions issued by the relevant Mainland authorities